Bronchial asthma
Conditions
Interventions
Group B:Budisonide+Bushen Fangchuan Pian(5 tablets,tid,orally taken for 12 weeks)
Group A:Budisonide+chinese drugs for reinforcing shen and supplementing qi(125ml,bid,orally taken for 12 weeks)
Group C:Budisonide+Chinese drugs for reinforcing shen and supplementing qi placebo+Bushen Fangchuan Pian placebo
Sponsors
Huashan Hospital Affiliated to Fudan University
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1.Aged 18 to 70 years old, male or female; 2.Able and willing to provide signed informed consent; 3.Patients with partial controlled and uncontrolled asthma, and using inhaled corticosteroid treatment continuously at least three months; 4.Qi deficiency syndrome,shen qi deficiency syndrome and deficiency of Shenyang syndrome according to Traditional Chinese medical Differentiation; 5.Without Respiratory tract infection and Acute asthma attack for the past four weeks.
Exclusion criteria
Exclusion criteria: 1. Patients with severe persistent asthma or acute asthma attack or Oral glucocorticoid treatment; 2. Participated in clinical trials of other drugs for the past three months; 3. Patients who have previous cancer treatments; 4. Uncontrolled heart failure/infection or Renal failure; 5. Previous diagnosis of COPD or other pulmonary diseases; 6. Hyperactivity of fire due to yin deficiency syndrome according to Traditional Chinese medical Differentiation; 7. Pregnant or planning pregnancy, breast-feeding women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Asthma control test; | — |
Secondary
| Measure | Time frame |
|---|---|
| Asthma symptoms, lung function, Asthma Quality of Life, Questionnaire, traditional Chinese syndrome, blood cell count; | — |
Countries
China
Contacts
Public ContactJingcheng Dong
Outcome results
None listed